NCT00225082View on ClinicalTrials.gov

SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

October 31, 2007

Conditions
HIV Infection
Interventions
DRUG

Nucleoside analogue switch

stavudine switched to tenofovir

Trial Locations (1)

60611

Northwestern University, Chicago

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Northwestern University

OTHER

NCT00225082 - SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function | Biotech Hunter | Biotech Hunter